People with aggressive melanomas could be spared the trauma of radiation treatments that wouldn’t work for them anyway thanks to world-first research at a Queensland hospital.
MRV Research
MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
This study will determine whether there is a difference in local recurrence rates and melanoma survival rates for patients treated with either a 1cm excision margin or 2cm margin for both intermediate & high risk melanomas.
T-VEC Approved in Europe for Unresectable Metastatic Melanoma
The European Commission has approved talimogene laherparepvec (T-VEC; Imlygic) as a treatment for adult patients with unresectable stage IIIb, IIIc, and IVM1a melanoma that has not spread to the bone, brain, lung, or other viscera, based on the phase III OPTiM study.
Biopsy-Free Detection of Melanoma Metastasis
According to the results of a new study, a new imaging technique is able to detect the distant spread of melanoma to the lymph nodes, which could help patients avoid potentially risk surgery. Researchers tested the non-invasive technique in a first-in-human study as a potential alternative to standard lymph node surgery.